Also known as: Alfentanyl
Alfentanil is indicated for:
Irrespective of gender only Adults (18 - 65 years old)
It is indicated for analgesia and suppression of respiratory activity in mechanically ventilated patients on intensive care and to provide analgesic cover for painful manoeuvres. It will aid compliance with mechanical ventilation, and tolerance of the endotracheal tube. Intravenous bolus doses of alfentanil (0.5 mg/ml) may be used to provide additional pain relief during brief painful procedures such as physiotherapy, endotracheal suction, etc. Despite being mechanically ventilated, patients may be awake in the presence of adequate analgesia.
For this indication, the medical literature mentions below treatments (click for details):
Active ingredient Alfentanil is contraindicated in the following cases:
Alfentanil is contraindicated in concurrent administration with monoamine oxidase inhibitors or within 2 weeks of their discontinuation.
No studies on the effects of alfentanil on the ability to drive and use machines have been performed. However, where early discharge is envisaged patients should be advised not to drive or operate machinery for at least 24 hours following administration.
This medicine can impair cognitive function and can affect a patient’s ability to drive safely. This class of medicine is in the list of drugs included in regulations under 5a of the Road Traffic Act 1988. When prescribing this medicine, patients should be told:
Alfentanil may appear in breast milk. Therefore, breast-feeding or use of expressed breast milk is not recommended within 24 hours following the administration of alfentanil.
Alfentanil is contraindicated in labour or before clamping of the cord during Caesarian section due to the possibility of respiratory depression in the new-born infant.
Alfentanil is contraindicated in obstructive airway disease or respiratory depression if not ventilating.